Annual CFO
-$91.51 M
+$7.00 M+7.11%
December 31, 2023
Summary
- As of February 7, 2025, OMGA annual cash flow from operations is -$91.51 million, with the most recent change of +$7.00 million (+7.11%) on December 31, 2023.
- During the last 3 years, OMGA annual CFO has fallen by -$65.38 million (-250.17%).
- OMGA annual CFO is now -483.65% below its all-time high of -$15.68 million, reached on December 31, 2019.
Performance
OMGA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$14.02 M
-$1.34 M-10.60%
September 30, 2024
Summary
- As of February 7, 2025, OMGA quarterly cash flow from operations is -$14.02 million, with the most recent change of -$1.34 million (-10.60%) on September 30, 2024.
- Over the past year, OMGA quarterly CFO has dropped by -$2.21 million (-18.72%).
- OMGA quarterly CFO is now -156.68% below its all-time high of -$5.46 million, reached on June 1, 2020.
Performance
OMGA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$55.58 M
+$9.02 M+13.97%
September 30, 2024
Summary
- As of February 7, 2025, OMGA TTM cash flow from operations is -$55.58 million, with the most recent change of +$9.02 million (+13.97%) on September 30, 2024.
- Over the past year, OMGA TTM CFO has increased by +$19.62 million (+26.09%).
- OMGA TTM CFO is now -869.68% below its all-time high of -$5.73 million, reached on March 31, 2020.
Performance
OMGA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
OMGA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.1% | -18.7% | +26.1% |
| 3 y3 years | -250.2% | -18.7% | +26.1% |
| 5 y5 years | -483.6% | -18.7% | +26.1% |
OMGA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.9% | +7.1% | -18.7% | +50.1% | at high | +46.2% |
| 5 y | 5-year | -483.6% | +7.1% | -156.7% | +50.1% | -869.7% | +46.2% |
| alltime | all time | -483.6% | +7.1% | -156.7% | +50.1% | -869.7% | +46.2% |
Omega Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.02 M(+10.6%) | -$55.58 M(-14.0%) |
| Jun 2024 | - | -$12.67 M(+7.3%) | -$64.60 M(-14.1%) |
| Mar 2024 | - | -$11.80 M(-30.9%) | -$75.20 M(-17.8%) |
| Dec 2023 | -$91.51 M(-7.1%) | -$17.09 M(-25.8%) | -$91.51 M(-7.2%) |
| Sep 2023 | - | -$23.04 M(-1.0%) | -$98.66 M(-1.8%) |
| Jun 2023 | - | -$23.27 M(-17.2%) | -$100.45 M(-2.7%) |
| Mar 2023 | - | -$28.11 M(+16.0%) | -$103.28 M(+4.8%) |
| Dec 2022 | -$98.52 M | -$24.24 M(-2.4%) | -$98.52 M(+9.2%) |
| Sep 2022 | - | -$24.84 M(-4.8%) | -$90.23 M(+10.2%) |
| Jun 2022 | - | -$26.09 M(+11.7%) | -$81.89 M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$23.35 M(+46.3%) | -$70.41 M(+22.2%) |
| Dec 2021 | -$57.61 M(+120.4%) | -$15.96 M(-3.3%) | -$57.61 M(+15.3%) |
| Sep 2021 | - | -$16.50 M(+12.9%) | -$49.95 M(+24.6%) |
| Jun 2021 | - | -$14.61 M(+38.5%) | -$40.10 M(+29.6%) |
| Mar 2021 | - | -$10.55 M(+27.1%) | -$30.95 M(+18.4%) |
| Dec 2020 | -$26.13 M(+66.7%) | -$8.30 M(+25.0%) | -$26.13 M(+46.5%) |
| Sep 2020 | - | -$6.64 M(+21.6%) | -$17.83 M(+59.3%) |
| Jun 2020 | - | -$5.46 M(-4.7%) | -$11.19 M(+95.3%) |
| Mar 2020 | - | -$5.73 M | -$5.73 M |
| Dec 2019 | -$15.68 M | - | - |
FAQ
- What is Omega Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Omega Therapeutics?
- What is Omega Therapeutics annual CFO year-on-year change?
- What is Omega Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Omega Therapeutics?
- What is Omega Therapeutics quarterly CFO year-on-year change?
- What is Omega Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Omega Therapeutics?
- What is Omega Therapeutics TTM CFO year-on-year change?
What is Omega Therapeutics annual cash flow from operations?
The current annual CFO of OMGA is -$91.51 M
What is the all time high annual CFO for Omega Therapeutics?
Omega Therapeutics all-time high annual cash flow from operations is -$15.68 M
What is Omega Therapeutics annual CFO year-on-year change?
Over the past year, OMGA annual cash flow from operations has changed by +$7.00 M (+7.11%)
What is Omega Therapeutics quarterly cash flow from operations?
The current quarterly CFO of OMGA is -$14.02 M
What is the all time high quarterly CFO for Omega Therapeutics?
Omega Therapeutics all-time high quarterly cash flow from operations is -$5.46 M
What is Omega Therapeutics quarterly CFO year-on-year change?
Over the past year, OMGA quarterly cash flow from operations has changed by -$2.21 M (-18.72%)
What is Omega Therapeutics TTM cash flow from operations?
The current TTM CFO of OMGA is -$55.58 M
What is the all time high TTM CFO for Omega Therapeutics?
Omega Therapeutics all-time high TTM cash flow from operations is -$5.73 M
What is Omega Therapeutics TTM CFO year-on-year change?
Over the past year, OMGA TTM cash flow from operations has changed by +$19.62 M (+26.09%)